Ezetimibe-d4-1
CAT:
804-HY-17376S1-03
Size:
1 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

Ezetimibe-d4-1
- CAS Number: 1093659-89-2
- UNSPSC Description: Ezetimibe-d4-1 is deuterium labeled Ezetimibe. Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.
- Target Antigen: Autophagy; Keap1-Nrf2
- Type: Isotope-Labeled Compounds
- Related Pathways: Autophagy;NF-κB
- Applications: Cancer-programmed cell death
- Field of Research: Cardiovascular Disease; Cancer
- Solubility: 10 mM in DMSO
- Smiles: OC1=CC=C([C@@H]2[C@H](C(N2C3=CC=C(C=C3)F)=O)CC[C@@H](C4=C(C([2H])=C(C([2H])=C4[2H])F)[2H])O)C=C1
- Molecular Weight: 413.45
- References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Chang E, et al. Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats. World J Gastroenterol. 2015 Jul 7;21(25):7754-63.|[3]Lee DH, et al. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radic Biol Med. 2016 Sep 12;99:520-532.
- Shipping Conditions: Blue Ice
- Clinical Information: No Development Reported